Paul Averback
Vermögen: 4 Mio $ am 30.06.2025
Vermögen: 4 Mio $ am 30.06.2025
Paul Averback is the founder of Nymox Pharmaceutical Corp.
since 1995, holding the title of Co-Chairman, President & Chief Executive Officer.
Former job includes President at DMS Pharmaceutical Group, Inc. Education includes a doctorate from the University of Cambridge, conferred in 1975.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NYMOX PHARMACEUTICAL CORP 37,43 % | 19.04.2025 | 35.008.010 ( 37,43 % ) | 4 Mio $ | 30.06.2025 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NYMOX PHARMACEUTICAL CORPORATION | Vorstandsvorsitzender | 30.09.1995 |
| Unternehmen | Position | Ende |
|---|---|---|
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Nymox Pharmaceutical Corp.
Nymox Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which specializes in the research and development of products for the aging population | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen